Cells in monolayers
Cell seeding -cells were seeded (0.2-0.4X 106) onto collagen coated Millicell-CM culture plate inserts (12 mm diameter), which were then placed in 12 well culture plates and incubated at 37°C in 5% carbon dioxide. Culture medium in inserts and wells was changed every 36 hours. The inserts consist of a transparent, low protein binding Biopore membrane, which allows live cells to be assessed by microscopy. Cell viability was also assessed by measuring the release of lactic dehydrogenase into the culture medium.18 Cells grow into polarised monolayers with the apical membrane uppermost and the basolateral membrane attached to the collagen coated membrane. 5-ASA was added to the apical surface (10 mM) or the basolateral surface (50 ,uM), and IFN-y, in different concentrations (0, 100, 500, and 3000 U/ml), was added to the basolateral surface after the monolayers developed a high electrical resistance.
Electron microscopy -electron microscopy was performed by Dr David Ferguson (John Radcliffe Hospital, Oxford, UK) on monolayers fixed in 4% glutaraldehyde. Electrical resistance -transepithelial resistance was measured using a Voltohmmeter (Millicel-ERS, Millipore UK). Monolayers were considered mature when electrical resistance had risen three to five days after seeding for Caco2 cells and 8-10 days after seeding for HT29:19A cells (see Fig 4) . Resistance was corrected for resistance of collagen coated inserts without cells. 
by gamma interferon t r ; Y ; ; $ j . S ; / * _ | S ¢ p < 8 t , . . . . s x , , , . . . . . . . . . . . to the apical surface of monolayers, which had been incubated for 72 hours. Samples (100 ,ul) were collected from the basolateral side of each insert at one, two, and four hours. These samples were added to 400 gl of distilled water and this was then added to scintillation fluid (Optiphase Safe, LKB Scintillation Products, Loughborough, UK) and counted in an LKB Scintillation counter (LKB Wallac, Uppsala, Sweden). Dpm were converted to pmol/cm2/h. 19 Immunohistochemistry -monolayers were embedded in OCT (Tissue-Tek, Miles, distributed by BDH, Poole, UK) and stored in liquid nitrogen. Subsequently, monolayers were cut and stained for HLA-DR (CR3-43 antibody, kindly supplied by Dr K Gatter, John Radcliffe Hospital, Oxford, UK) and ICAM-1 (antibody against ICAM-1:18711, British Biotechnology, UK). In each case the second antibody was a peroxidase labelled rabbit antimouse IgG (Dako).
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Statistical analysis -of transepithelial resistance and mannitol flux data was performed by analysis of variance.
Results
Induction ofHLA-DR IFNy at all concentrations tested (100, 500, and 3000 U/ml) failed to induce HLA-DR expression on Caco2 cells (n=3). Expression was induced in HT29: 19A cells (n=3), however, in a dose and time dependent manner. Virtually all cells incubated with 3000 U/ml IFNy stained for HIA-DR (Fig 1) .
Cell monolayers For both Caco2 and HT29:19A monolayers, electron microscopy confirmed the polarity of the cells, the presence of tight junctions, and the absence of evidence of cell death after incubation with IFNy with or without 5-ASA for 72 hours (Fig 2) . The addition of IFNy with or without 5-ASA did not increase release of lactic dehydrogenase (data not shown).
Caco2 monolayers -IFNy added to the basolateral surface at a concentration of 500 U/ml did not induce HLA-DR expression in Caco2 cell monolayers (n= 6) confirming results obtained using cell suspensions. IFNy did not affect the barrier function of the monolayers as assessed by transepithelial resistance or mannitol flux (Fig 3) .
Monolayers of HT29:19A -cells did not express HIA-DR when cultured in medium alone but there was weak expression of ICAM-1. After the addition of IFNy there was strong expression of both HLA-DR and ICAM-1 in a dose and time dependent manner. The expression of both molecules was reduced by addition of 50 KuM 5-ASA to the basolateral surface of the insert.
Electrical resistance across the monolayers increased with time but was reduced by IFNy in a dose dependant fashion (Fig 4) . 5-ASA applied to the basolateral surface (50 ,uM) or to the apical surface (10 mM) did not affect the response to IFNy. The Table and Using HT29 cells, we have previously shown that 5-ASA is able to inhibit the induction of HLA-DR by IFNy.6 This effect is mediated by competitive binding of 5-ASA to the IFNy receptor on the epithelial cell."1 The present data confirm this finding in high resistance monolayers. Inhibition was only seen, however, when 5-ASA was applied to the basolateral surface. This is consistent with the finding that receptors for IFNy are confined to the basolateral membrane. 22 23 There was no effect when 5-ASA was applied to the apical surface at the much higher concentration present in the lumen of patients taking 5-ASA containing compounds. As aminosalicylates are poorly absorbed from the colonic lumen, it is unlikely that 5-ASA added to the apical surface of HT29:19A monolayers can cross to the basolateral surface to inhibit the binding of IFNy to its receptor. Our previous studies showed that the acetylated metabolites of aminosalicylates also impair IFNy binding and HLA-DR induction.6 11 In contrast with normal colonic epithelium, however, HT-29 cells have a limited capacity to metabolise 5-ASA, and it is probable that there is very little N-acetyl 5-ASA on the basolateral surface of the HT29:19A monolayers.24
Transepithelial 14C mannitolflux (pmol/cm2/h) across HT29:19A cell monolayers measured during a four hour period after 72 hours incubation with IFNy with or without 50 /uM 5-ASA applied to the basolateral surface. Mean The mechanism of action of aminosalicylates in inflammatory bowel disease is not known. Intestinal permeability is increased in patients with inflammatory bowel disease and these findings suggest that 5-ASA could improve the barrier function of the colonic epithelium, thus reducing access of luminal antigens to mucosal immune cells.25
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